LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

Search

Treace Medical Concepts Inc

Fechado

2.59 -4.78

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.58

Máximo

2.81

Indicadores-chave

By Trading Economics

Rendimento

1.1M

-16M

Vendas

2.8M

50M

EPS

-0.222

Margem de lucro

-32.437

Funcionários

477

EBITDA

1.3M

-12M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+101.1% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-232M

184M

Abertura anterior

7.37

Fecho anterior

2.59

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de nov. de 2025, 23:07 UTC

Conversa de Mercado

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20 de nov. de 2025, 22:22 UTC

Conversa de Mercado

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20 de nov. de 2025, 22:08 UTC

Conversa de Mercado

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20 de nov. de 2025, 21:57 UTC

Ganhos

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20 de nov. de 2025, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

20 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

20 de nov. de 2025, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

20 de nov. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

20 de nov. de 2025, 21:31 UTC

Ganhos

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20 de nov. de 2025, 21:23 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 de nov. de 2025, 21:07 UTC

Ganhos

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 de nov. de 2025, 21:06 UTC

Ganhos

Webull 3Q Rev $156.9M >BULL

20 de nov. de 2025, 21:06 UTC

Ganhos

Webull 3Q EPS 7c >BULL

20 de nov. de 2025, 21:05 UTC

Ganhos

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20 de nov. de 2025, 21:04 UTC

Ganhos

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20 de nov. de 2025, 21:04 UTC

Ganhos

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20 de nov. de 2025, 21:04 UTC

Ganhos

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit 1Q Consumer Rev $894M

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Backs FY26 Guidance

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20 de nov. de 2025, 21:00 UTC

Ganhos

Intuit 1Q Global Business Solutions Rev $3B

Comparação entre Pares

Variação de preço

Treace Medical Concepts Inc Previsão

Preço-alvo

By TipRanks

101.1% parte superior

Previsão para 12 meses

Média 5.47 USD  101.1%

Máximo 7.5 USD

Mínimo 4 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Treace Medical Concepts Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

1

Comprar

4

Manter

1

Vender

Pontuação Técnica

By Trading Central

7.16 / 7.65Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat